Skip to content

Clinical trials

Expanded access trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: Singapore Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20121
20151

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Approved for marketing8
Available3
No longer available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Nuvalent Inc.2
Pfizer2
Astellas Pharma Global Development, Inc.1
AstraZeneca1
Changi General Hospital1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Novartis1
Novartis Pharmaceuticals1
Singapore General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung4
Breast Neoplasms3
Adenocarcinoma1
Carcinoma, Medullary1
Carcinoma, Renal Cell1
Colonic Neoplasms1
Gastrointestinal Neoplasms1
Genital Diseases, Male1
Genital Neoplasms, Male1
Hypertension1

Trials

Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.